Instructions to Authors


The Journal of Taiwan Pharmacy (JTP) is the Editorial and peer-reviewed publication of the Union of Pharmacist Association, Taiwan, based in Taipei. The JTP invites original contributions relating to all fields of pharmacy and related disciplines that are of interest to the pharmaceutical profession.


Manuscript Submission

Methods of submission

You may submit your manuscript and figures as e-mail attachments to the JTP Editorial Office at:

Alternatively, you can submit your manuscript on a 3.5” floppy disk or CD-R and post it, together with two hard copies of your manuscript (that matches the disk file exactly) and a cover letter (that includes your name, address, telephone and fax numbers, and e-mail address), to:

Editorial Office

The Journal of Taiwan Pharmacy

The Union of Pharmacist Association, Taiwan 

5th floor, No. 67, Sec. 1, Ming Chuan East Road, Taipei, Taiwan

If there are figures, please also enclose two sets of the original figures to the Editorial Office at the above address. They will not be returned.


Manuscript file requirements

The complete manuscript should be in one Microsoft Word document (*.doc) file. The manuscript should include the following: abstract, main text, references, tables and table headings, and figure legends.
Each figure should be submitted as a separate high resolution picture file.


Previous Publication / Duplicate Submission


Submitted manuscripts are considered with the understanding that they have not been published previously in print or electronic format (except in abstract or poster form) and are not under consideration by another publication or electronic medium.


Basic Criteria


Articles should be written in English (using American English spelling) and meet the following basic criteria: the material is important, the material is original, the writing is clear and concise, the study methods are appropriate, the data are valid, and the conclusions are reasonably supported by the data.


Article Categories


The categories of articles that are published are

-         Original Articles

-         News and Perspectives

-         Review Articles

-         Case Reports

-         Brief Communications of Professional Work

-         Letters to the Editor


Manuscript Preparation



A concise abstract contains no more than 300 words and up to 6 relevant key words in alphabetical order. Abstracts should be structured with the section headings:

        1. Background/Objectives

        2. Patients/Materials and Methods

        3. Results

        4. Discussion and Conclusion


Abstracts (no more than 300 words) for Case Reports and Brief Communications are unstructured, but should nevertheless include the information on the above sections.



Main Text

For original articales (no more than 5 authors), the main text (should be 3000 words, double space) should include the following sections: introduction, Materials and Methods, Results, and Discussion.



Abbreviations should be kept to a minimum, where a term/definition will be continually referred to, it must be written in full, followed by the subsequent abbreviation in brackets, when it first appears in the abstract and text. The abbreviation may be used thereafter.


Drug Names

Unless the trade name of a medicine is directly relevant to the discussion, use the generic name or the Recommended International Non-proprietary Name.



Please use Systemic International (SI) units for all hematologic and clinical biochemistry tests, except blood pressure which is reported in mmHg. Please use metric system for the expression of length, height, weight, mass, volume and area.

For exemples:

cm, mm, μm, L, dL, mL, μL, kg, g, mg, μg, ng, pg, kcal, , msec, mm3, %, mol, mol/L, mg/dL, Ci, Hz.  



The number of references should not exceed 15.

1.      1. Each reference citation within the main text should be a superscript Arabic number.

2.      2. References should be numbered consecutively in order of appearance in the text, and listed in number order in the reference list.

3.      3. References should include the authors’ last names and initials (upto three authors, if more than three, list only three followed by “et al”), complete title of the article, journal name, year, volume number, and first and last page numbers.

4.      4.  References to books should include the authors’ last names and initials (upto three authors, if more than three, list only three followed by “et al”), complete title of the chapter, names of the book’s editors, complete title of the book, city of publication, publisher, year of publication and inclusive page numbers of the cited chapter, volume of edition numbers should be included when appropriate.

5.      5.  If you cite information from a website, please provide the author information, article title, the website address and the date you accessed the information.  

For exemples:

1. Hsieh BS, Chen WY: Renal prostaglandin E in essential hypertension: studies in patients with suppressed rennin activity. J Formos Med Assoc 1981;80:575-81

2. Hsien BS, Chang CC, Chen Fw, et al: Renal prostaglandin E in pheochromocytoma, J Formos Med Assoc 1984;83:821-7.

3. Kaplan NW:Coronary heart disease risk factors and anti-hypertensive drug selection. J Cardiovasc Pharmacol 1982;4(Suppl 2):186-35

4. Anonymous: Neurovirulence of enterovirus 70 [Editorial]. Lancet 1982;1:373-4.

5. Tada A, Hisada K, Suzuki T, Kadoya S: Volume measurement of intracranial hematoma by computed tomography. Neurol Surg(Tokyo)1981;9:251-6.[In Japanese;Englist abstract] 

6. Plum F, Posner JB: Diagnosis of stupor and coma,3rd ed. Philadelphia, Davis, 1980:132-3.

7. Levinsky NG: Fluid and electrolytes. In: Thorn GW, Adams RD, Braunwald E, Isselbacher K, Petersdorf RG, eds. Harrison's Principles of Internal Medicine, 8th ed. New York. McGraw-Hill, 1977:364-75.

8. Kurland LT: The epidemiologic characteristics of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology, vol 9. Multiple Sclerosis and Other Demyelinating Diseases Amsterdam, North-Holland, 1970:63-84.

9. Adams JH: Central pontine myelinolysis. In: Proceedings of the 4th International Congress of Nuropathology, 1961. Munich; Vol 3. Stuttgart, Thieme, 1962:303-8.

10.Hung TP. Chiang TR:Multiple sclerosis in Taiwan: clinical, electrophysiological and epidemiological studies [Abstract]. 6th Asian and Oceanian Congress of Neurology, 1983. Taipei. Hong Kong, Excerpta Medica, Asia Pacific Congress Series No 22, 1983:28.

11.Cairns RB: Infrared spectroscopic studies of solid oxygen [Dissertation]. Berkeley, California: University of California, 1965. 156p

12.Eastman Kodak Company. Eastman Organic Chemicals. Rochester NY, Catalog No 49, 1977. 187p


 News and Perspectives


These are comments on recent news and should provide a short review (no more than 3000 words, no more than 5 authors) of the current research state and explain the importance of the new findings. These are focused on paper published in the Journal of Taiwan Pharmacy. We welcome proposal from potential authors.


 Review Articles


Review articles (no more than 3000 words) are important assessments of topic issues in clinical pharmaceutical practice or research. The number of references should not exceed 15.


Case reports


Case reports should have no more than 5 authors. The abstract should be no longer than 300 words and should include statements of the problem, drug therapy, and outcome. The main text should include the problem of the case, patient history, diagnosis drug therapy, results and any other information pertinent to the case(s). All other sections should follow the format for the “Original Articles”. The number of references should not exceed 8.


 Brief Communications


Brief communications should have no more than 5 authors and should be concise (no more than 300 words) in presenting the clinical or pharmaceutical notes, or preliminary experimental results. The number of references should not exceed 8.


 Letters to the Editor


 Letters to the editor (no more than 300 words, no more than 8 references) are welcome in response to articles previously published in the JTP.




  Published manuscripts become the permanent property of the Publisher, the JTP and the Union of Pharmacist Association, Taiwan, and may not be published elsewhere, in any media, and in any language, without written permission.